Drug Trial Radar · NCT03672175
A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Nov 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
581
Actual
Start
Nov 19, 2018
Primary completion
Sep 24, 2019
Study completion Mar 17, 2020
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Sep 14, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a phase 3, multicenter, double-blind, randomized, placebo-controlled study evaluating the efficacy of SAGE-217 in the treatment of adult participants with major depressive disorder (MDD).
Conditions
- Major Depressive Disorder
Interventions
SAGE-217Drug
SAGE-217 hard gelatin capsules.
PlaceboDrug
SAGE-217 matched placebo hard gelatin capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the 17-item HAM-D Total Score at Day 15Time frame: Baseline (BL), Day 15
Locations
53 sites in 1 country. Site status is shown where the registry gives one.
Sage Investigational Site
Rogers, Arkansas
Sage Investigational Site
Bellflower, California
Sage Investigational Site
Garden Grove, California
Sage Investigational Site
Glendale, California
Sage Investigational Site
National City, California
Sage Investigational Site
Oakland, California
Sage Investigational Site
Oceanside, California
Sage Investigational Site
Orange, California
Sage Investigational Site
Pico Rivera, California
Sage Investigational Site
Redlands, California
Sage Investigational Site
San Diego, California
Sage Investigational Site
Sherman Oaks, California
Sage Investigational Site
Temecula, California
Sage Investigational Site
Coral Springs, Florida
Sage Investigational Site
Hollywood, Florida
Sage Investigational Site
Jacksonville, Florida
Sage Investigational Site
Lauderhill, Florida
Sage Investigational Site
Maitland, Florida
Sage Investigational Site
North Miami, Florida
Sage Investigational Site
Orange City, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Atlanta, Georgia
Site Investigational Site
Decatur, Georgia
Sage Investigational Site
Skokie, Illinois
Sage Investigational Site
Pikesville, Maryland
Sage Investigational Site
Flowood, Mississippi
Sage Investigational Site
Flowood, Mississippi
Sage Investigational Site
O'Fallon, Missouri
Sage Investigational Site
St Louis, Missouri
Sage Investigational Site
Las Vegas, Nevada
Sage Investigational Site
Berlin, New Jersey
Sage Investigational Site
Jamaica, New York
Sage Investigational Site
Rochester, New York
Sage Investigational Site
Charlotte, North Carolina
Sage Investigational Site
Cincinnati, Ohio
Sage Investigational Site
Dayton, Ohio
Sage Investigational Site
North Canton, Ohio
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.